Cargando…
Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro
Cachexia syndrome, leading to reduced skeletal muscle and fat mass, is highly prevalent in cancer patients, resulting in further negative implications for these patients. To date, there is no approved therapy for cachexia syndrome. The objective of this study was to establish an in vitro model of ca...
Autores principales: | Noone, John, Rooney, Mary F., Karavyraki, Marilena, Yates, Andrew, O’Sullivan, Saoirse E., Porter, Richard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675367/ https://www.ncbi.nlm.nih.gov/pubmed/38004445 http://dx.doi.org/10.3390/ph16111580 |
Ejemplares similares
-
The Peripheral Cannabinoid Receptor Type 1 (CB(1)) as a Molecular Target for Modulating Body Weight in Man
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2021) -
Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma
por: Karavyraki, Marilena, et al.
Publicado: (2022) -
Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2022) -
Purified lectin from skeletal muscle inhibits myotube formation in vitro
Publicado: (1980) -
Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro
por: Baker, Luke A., et al.
Publicado: (2022)